| CYSB2200138 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2022-06-07 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB2200109 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2022-04-29 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CYSB2400114 | 静注人免疫球蛋白（pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2024-05-15 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2200604 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.4) | New Drug Application | 2022-12-16 | | Guangdong Danxia Biology Pharmcy Co Ltd | | | view |
| CYSB2400267 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2024-10-10 | | Guangdong Shuanglin Bio-Pharmacy Co Ltd | | | view |
| CXSL2200012 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(3.4) | New Drug Application | 2022-01-12 | | Guangdong Danxia Biology Pharmcy Co Ltd | | | view |
| CYSB2400061 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2024-03-01 | | China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd | | | view |
| CYSB2200137 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2022-06-07 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CXSL2200229 | 静注人免疫球蛋白 | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2022-05-27 | | Shenzhen Weiguang Biological Products Co Ltd | | | view |
| CYSB2101111 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-07-13 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| CYSB2200067 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2022-03-01 | | Shenzhen Weiguang Biological Products Co Ltd | | | view |
| CYSB2400096 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2024-04-25 | | Green Cross China Biological Products Co Ltd | | | view |
| CYSB2101160 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-08-18 | | Hualan Biological Engineering Inc | | | view |
| CYSB2400260 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products(3.4) | Supplementary Application | 2024-09-26 | | Shanxi Kangbao Biological Product Co Ltd | | | view |
| CYSB2101073 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2021-05-24 | | Hualan Biological Engineering Inc | | | view |
| CXSL2200230 | 静注人免疫球蛋白 | human immunoglobulin(PH4) | Injection | Biological Products(3.2) | New Drug Application | 2022-05-27 | | Shenzhen Weiguang Biological Products Co Ltd | | | view |
| CYSB2200135 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2022-06-07 | | Shanghai RAAS Blood Products Co Ltd | | | view |
| CYSB2400058 | 静注人免疫球蛋白(pH4) | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2024-03-01 | | China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd | | | view |
| CYSB2200071 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2022-03-10 | | Green Cross China Biological Products Co Ltd | | | view |
| CYSB2400097 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2024-04-25 | | Green Cross China Biological Products Co Ltd | | | view |
